Li Mario W T, Poon Sarah W Y, Cheung Claudia, Wong Chris K C, Shing Matthew M K, Chow Terry T W, Lee Samantha L K, Pang Gloria S W, Kwan Elaine Y W, Poon Grace W K, Yau Ho-Chung, Tung Joanna Y L, Liu Anthony P Y
Department of Paediatrics and Adolescent Medicine, The Hong Kong Children's Hospital, Hong Kong, China.
Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, Hong Kong, China.
Cancers (Basel). 2023 Aug 2;15(15):3935. doi: 10.3390/cancers15153935.
With the increasing use of magnetic resonance imaging (MRI) in the evaluation of children with endocrine disorders, pituitary stalk thickening (PST) poses a clinical conundrum due to the potential for underlying neoplasms and challenges in obtaining a tissue biopsy. The existing literature suggests Langerhans cell histiocytosis (LCH) to be the commonest (16%) oncologic cause for PST, followed by germ cell tumors (GCTs, 13%) (CCLG 2021). As the cancer epidemiology varies according to ethnicity, we present herein the incidence and predictors for oncologic etiologies in Hong Kong Chinese children with PST.
Based on a territory-wide electronic database, we reviewed patients aged < 19 years who presented to three referral centers with endocrinopathies between 2010 and 2022. Records for patients who underwent at least one MRI brain/pituitary were examined ( = 1670): those with PST (stalk thickness ≥ 3 mm) were included, while patients with pre-existing cancer, other CNS and extra-CNS disease foci that were diagnostic of the underlying condition were excluded.
Twenty-eight patients (M:F = 10:18) were identified. The median age at diagnosis of PST was 10.9 years (range: 3.8-16.5), with central diabetes insipidus (CDI) and growth hormone deficiency (GHD) being the most frequent presenting endocrine disorders. At a median follow-up of 4.8 years, oncologic diagnoses were made in 14 patients (50%), including 13 GCTs (46%; germinoma = 11, non-germinoma = 2) and one LCH (4%). Among patients with GCTs, 10 were diagnosed based on histology, two by abnormal tumor markers and one by a combination of histology and tumor markers. Three patients with germinoma were initially misdiagnosed as hypophysitis/LCH. The cumulative incidence of oncologic diagnoses was significantly higher in boys and patients with PST at presentation ≥6.5 mm, CDI or ≥2 pituitary hormone deficiencies at presentation and evolving hypopituitarism (all < 0.05 by log-rank).
A higher rate of GCTs was observed in Chinese children with endocrinopathy and isolated PST. The predictors identified in this study may guide healthcare providers in Asia in clinical decision making. Serial measurement of tumor markers is essential in management.
随着磁共振成像(MRI)在评估内分泌疾病儿童中的应用日益增加,垂体柄增厚(PST)由于潜在的肿瘤以及获取组织活检的挑战而带来了临床难题。现有文献表明,朗格汉斯细胞组织细胞增多症(LCH)是PST最常见的肿瘤学病因(16%),其次是生殖细胞肿瘤(GCTs,13%)(中国儿童白血病协作组,2021年)。由于癌症流行病学因种族而异,我们在此介绍香港中国儿童PST肿瘤学病因的发病率及预测因素。
基于一个全港性的电子数据库,我们回顾了2010年至2022年间在三家转诊中心就诊的年龄小于19岁的内分泌疾病患者。检查了至少接受过一次脑部/垂体MRI检查的患者记录(n = 1670):纳入有PST(柄厚度≥3 mm)的患者,排除已有癌症、其他中枢神经系统和中枢神经系统外疾病病灶且可诊断潜在疾病的患者。
共确定了28例患者(男:女 = 10:18)。PST诊断时的中位年龄为10.9岁(范围:3.8 - 16.5岁),中枢性尿崩症(CDI)和生长激素缺乏症(GHD)是最常见的首发内分泌疾病。中位随访4.8年时,14例患者(50%)被诊断为肿瘤,包括13例GCTs(46%;生殖细胞瘤 = 11例,非生殖细胞瘤 = 2例)和1例LCH(4%)。在GCTs患者中,10例根据组织学诊断,2例根据异常肿瘤标志物诊断,1例根据组织学和肿瘤标志物联合诊断。3例生殖细胞瘤患者最初被误诊为垂体炎/LCH。男性以及PST厚度≥6.5 mm、就诊时患有CDI或≥2种垂体激素缺乏症以及出现垂体功能减退的患者,肿瘤诊断的累积发生率显著更高(所有p值通过对数秩检验均<0.05)。
在内分泌疾病合并孤立性PST的中国儿童中观察到较高的GCTs发生率。本研究中确定的预测因素可能指导亚洲的医疗保健提供者进行临床决策。肿瘤标志物的系列测量在管理中至关重要。